FFCP PHASE2:Hg19::chr1:27022164..27022220,+
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
| Short description: | p2@ARID1A |
|---|---|
| Species: | Human (Homo sapiens) |
| DPI dataset: | Robust |
| TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
| DHS support(Yes/No): | Yes |
| Description: | CAGE_peak_2_at_ARID1A_5end |
| Coexpression cluster: | NA |
| Association with transcript: | -301bp_to_NM_006015, NM_139135, uc001bmt.1, uc001bmu.1, uc001bmv.1_5end |
| EntrezGene: | ARID1A |
| HGNC: | 11110 |
| UniProt: | O14497Q4LE49 |
| Genome view: | ZENBU |
View on UCSC genome browser
Mouse over to see Genome browser image, Click image to go to Genome browser
CAGE Expression
| Sample | p2@ARID1A |
|---|
0
10
20
30
40
50
60
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
| Ontology term | p-value | n |
|---|---|---|
| hematopoietic cell | 7.40e-17 | 177 |
| hematopoietic stem cell | 1.81e-16 | 168 |
| hematopoietic oligopotent progenitor cell | 3.09e-14 | 161 |
| hematopoietic multipotent progenitor cell | 3.09e-14 | 161 |
| lymphocyte | 6.45e-14 | 53 |
| common lymphoid progenitor | 6.45e-14 | 53 |
| lymphoid lineage restricted progenitor cell | 1.14e-13 | 52 |
| lymphocyte of B lineage | 2.85e-08 | 24 |
| pro-B cell | 2.85e-08 | 24 |
| leukocyte | 8.20e-08 | 136 |
Showing 1 to 10 of 12 entries
| Ontology term | p-value | n |
|---|---|---|
| hematologic cancer | 1.11e-14 | 51 |
| immune system cancer | 1.11e-14 | 51 |
| leukemia | 2.15e-13 | 39 |
| myeloid leukemia | 8.69e-12 | 31 |
Showing 1 to 4 of 4 entries
